Summer Road LLC
CIK 0001604873 Name as filed on the most recent filing
Filed as Summer Road LLC (17)
34 transaction lines · from 17 filings · filed 2020-03-17 to 2024-02-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
34 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2024-02-26 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 930,851 acquired | 7.52 | 6,999,999.52 | Form 4, filing 0000893838-24-000022 | |
| 2023-12-14 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 1,538,461 acquired | 3.25 | 4,999,998.25 | Form 4, filing 0000893838-23-000086 | |
| 2022-11-07 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 7,328 acquired | 3.50 | 25,648.00 | Form 4, filing 0001567619-22-019384 | |
| 2022-10-11 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 10,000 acquired | 3.90 | 38,993.00 | Form 4, filing 0001567619-22-018444 | |
| 2022-10-10 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 10,000 acquired | 4.00 | 39,982.00 | Form 4, filing 0001567619-22-018444 | |
| 2022-09-29 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 18,800 acquired | 4.04 | 75,987.72 | Form 4, filing 0001567619-22-017965 | |
| 2022-09-28 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 1,200 acquired | 4.10 | 4,920.00 | Form 4, filing 0001567619-22-017965 | |
| 2022-09-27 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 130,000 acquired | 4.68 | 608,322.00 | Form 4, filing 0001567619-22-017965 | |
| 2022-02-23 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 10,000 acquired | 4.80 | 47,986.00 | Form 4, filing 0001567619-22-005374 | |
| 2022-02-18 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 40,000 acquired | 5.00 | 199,940.00 | Form 4, filing 0001567619-22-005374 | |
| 2022-01-28 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 4,023 acquired | 5.20 | 20,919.60 | Form 4, filing 0001567619-22-002090 | |
| 2022-01-27 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 1,477 acquired | 5.20 | 7,680.40 | Form 4, filing 0001567619-22-002090 | |
| 2022-01-24 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 44,400 acquired | 5.31 | 235,892.76 | Form 4, filing 0001567619-22-001593 | |
| 2022-01-21 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 12,152 acquired | 5.56 | 67,531.09 | Form 4, filing 0001567619-22-001593 | |
| 2022-01-20 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 17,948 acquired | 5.70 | 102,384.37 | Form 4, filing 0001567619-22-001593 | |
| 2022-01-18 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 6,807 acquired | 6.00 | 40,827.02 | Form 4, filing 0001567619-22-001260 | |
| 2022-01-14 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 33,193 acquired | 6.03 | 200,110.64 | Form 4, filing 0001567619-22-001260 | |
| 2022-01-13 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 10,000 acquired | 6.20 | 61,983.00 | Form 4, filing 0001567619-22-001260 | |
| 2021-12-15 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 15,000 acquired | 6.22 | 93,246.00 | Form 4, filing 0001567619-21-022197 | |
| 2021-12-14 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 29,490 acquired | 6.41 | 189,175.40 | Form 4, filing 0001567619-21-022197 | |
| 2021-12-13 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 10,510 acquired | 6.50 | 68,302.39 | Form 4, filing 0001567619-21-022066 | |
| 2021-12-10 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 30,000 acquired | 6.65 | 199,494.00 | Form 4, filing 0001567619-21-022066 | |
| 2021-12-08 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 5,300 acquired | 6.75 | 35,775.00 | Form 4, filing 0001567619-21-021781 | |
| 2021-12-06 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 55,600 acquired | 6.13 | 340,828.00 | Form 4, filing 0001567619-21-021781 | |
| 2020-10-16 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 437 acquired | 10.48 | 4,579.76 | Form 4, filing 0001567619-20-017996 | |
| 2020-05-19 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 363,636 acquired | 5.50 | 1,999,998.00 | Form 4, filing 0001567619-20-010898 | |
| 2020-03-24 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 35,052 acquired | 4.87 | 170,713.76 | Form 4, filing 0001567619-20-006975 | |
| 2020-03-23 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 64,948 acquired | 4.66 | 302,365.41 | Form 4, filing 0001567619-20-006975 | |
| 2020-03-20 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 9,100 acquired | 4.52 | 41,119.26 | Form 4, filing 0001567619-20-006975 | |
| 2020-03-19 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 40,900 acquired | 4.63 | 189,223.85 | Form 4, filing 0001567619-20-006870 | |
| 2020-03-18 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 344,938 acquired | 4.62 | 1,594,199.95 | Form 4, filing 0001567619-20-006870 | |
| 2020-03-17 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 550,000 acquired | 4.66 | 2,562,890.00 | Form 4, filing 0001567619-20-006639 | |
| 2020-03-16 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 194,262 acquired | 4.16 | 807,216.89 | Form 4, filing 0001567619-20-006639 | |
| 2020-03-13 |
Ocular Therapeutix, Inc OCUL |
P, Open-market purchase | 210,800 acquired | 4.63 | 975,982.92 | Form 4, filing 0001567619-20-006639 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 34
- Open-market sale 0
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. SUMMER ROAD LLC, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001604873
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6